Bupe side effects
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Buprenorphine: A Comprehensive Overview
Introduction to Buprenorphine Side Effects
Buprenorphine (BUP) is a partial opioid agonist commonly used in the treatment of opioid dependence and pain management. While it is effective in these roles, it is essential to understand the potential side effects associated with its use. This article synthesizes findings from multiple studies to provide a clear picture of the side effects of buprenorphine.
Common Side Effects of Buprenorphine
Sedation and Drowsiness
Sedation and drowsiness are frequently reported side effects of buprenorphine. In a study involving heroin-dependent individuals, sedation was noted as a probable side effect, although it was considered an anticipated drug effect rather than an adverse reaction3. This aligns with findings from other studies where sedation was a common side effect in both acute and chronic pain management settings4 6.
Gastrointestinal Symptoms
Constipation is another prevalent side effect of buprenorphine. In the same study on heroin-dependent individuals, constipation was reported by a significant number of participants3. This side effect is consistent across various studies, indicating that gastrointestinal discomfort is a common issue for patients on buprenorphine4.
Headache and Insomnia
Headache and insomnia have also been identified as side effects in patients using buprenorphine for smoking cessation in schizophrenic patients. These side effects were noted alongside other minor gastrointestinal symptoms1.
Serious Side Effects
Respiratory Depression
While buprenorphine is known to have a ceiling effect on respiratory depression, it can still cause significant adverse effects on respiratory function in clinical settings. This is particularly important in the context of acute pain management, where respiratory depression remains a concern4 5.
Hepatic Dysfunction
There is some evidence suggesting that buprenorphine may be associated with increases in serum aminotransferase levels, indicating potential hepatic dysfunction. However, these increases could not be directly attributed to buprenorphine, and further studies are needed to delineate this risk3.
Comparative Side Effects with Other Opioids
Pruritus
One notable advantage of buprenorphine over other opioids like morphine is its lower incidence of pruritus (itching). A systematic review and meta-analysis found that buprenorphine use was associated with significantly less pruritus compared to morphine, making it a preferable option for patients who experience this side effect with other opioids4.
Abuse Potential and Dependence
Buprenorphine has a lower risk of abuse and dependence compared to full opioid agonists like methadone. This is partly due to its partial agonist properties and the availability of formulations that include naloxone, which reduces the risk of diversion and misuse5 7.
Conclusion
Buprenorphine is a valuable medication for the treatment of opioid dependence and pain management, but it is not without its side effects. Common issues include sedation, constipation, headache, and insomnia, while more serious concerns involve respiratory depression and potential hepatic dysfunction. However, buprenorphine's lower incidence of pruritus and reduced abuse potential make it a safer alternative to other opioids in many cases. Understanding these side effects can help healthcare providers make informed decisions about its use in various clinical settings.
Sources and full results
Most relevant research papers on this topic
A placebo controlled trial of bupropion for smoking cessation in schizophrenia
Bupropion SR effectively increases smoking abstinence rates in nicotine-dependent schizophrenic smokers, is well-tolerated, and may enhance smoking cessation outcomes when combined with atypical antipsychotics.
RCT
Highly CitedComparison of 0.5% Intrathecal Bupivacaine With 0.5% Intrathecal Ropivacaine in the Treatment of Refractory Cancer and Noncancer Pain Conditions: Results From a Prospective, Crossover, Double-Blind, Randomized Study
Intrathecal ropivacaine does not show advantages over bupivacaine for treating "refractory" pain, with higher daily doses and higher costs.
RCTSafety and side-effects of buprenorphine in the clinical management of heroin addiction.
Buprenorphine is well-tolerated in heroin addiction treatment, with expected side effects of sedation and constipation, but further study is needed to determine its potential risk for hepatic dysfunction.
Non-RCTHighly CitedEfficacy and adverse effects of buprenorphine in acute pain management: systematic review and meta‐analysis of randomised controlled trials
Buprenorphine is an equally effective analgesic agent as morphine in acute pain management, but may cause significant adverse effects on respiratory function.
Meta-Analysis
Very Rigorous JournalTreatment of opioid dependence with buprenorphine: current update
Buprenorphine (BUP) is a less dangerous and diversion-prone treatment for opioid dependence compared to methadone (MET), with lower respiratory depression risks and reduced diversion risks.
Literature ReviewComparisons of Analgesic Potency and Side Effects of Buprenorphine and Buprenorphine With Ultra-low-dose Naloxone
Buprenorphine combined with ultra-low-dose naloxone is not more effective in reducing pain than buprenorphine alone.
RCTBU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates.
BU10038 shows potential as a safe, non-addictive opioid analgesic with fewer side-effects in primates, offering an alternative solution to the ongoing prescription opioid crisis.
Non-RCT
Animal StudyVery Rigorous JournalPrescribing the Buprenorphine Monoproduct for Adverse Effects of Buprenorphine-Naloxone
The buprenorphine monoproduct (BUP) is effective and sometimes tolerated better than Buprenorphine-naloxone for treating opioid use disorder, but practice guidelines and insurance restrictions hinder its prescription due to concerns about diversion and injection.
The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users
Buprenorphine has abuse liability when administered intravenously or intranasally, with intravenous use having a greater effect than intranasal use.
Meta-AnalysisTreatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories.
Using an objective measure of opioid withdrawal during buprenorphine/naloxone induction can improve retention early in treatment.
Observational Study